africa-news.info
Merck Intensifies Research Initiatives To Fight Schistosomiasis
Pediatric Praziquantel Consortium starts pivotal Phase III study to address an unmet need in paediatric schistosomiasis in KenyaNeglected tropical disease schistosomiasis affects almost 240 million people worldwide and causes about 200,000 deaths per yearMerck, a leading science and technology company, today announced that, as part of its integrated Schistosomiasis Elimination Program, it is intensifying the...